Journal info
|
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics Neoplasma 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Neoplasma Vol.68, No.1, p.180–189, 2021 |
||
Title: The impact of 18F-FDG PET/CT in the clinical management of patients with lymph node metastasis of unknown primary origin | ||
Author: Petya Nikolaeva Nikolova, Valeria Hristova Hadzhiyska, Kiril Blagoev Mladenov, Mihaela Georgieva Ilcheva, Stefani Veneva, Violeta Vasileva Grudeva, Svetla Emilova Dineva, Yavor Nikolov Asenov | ||
Abstract: The aim of this study was to evaluate the diagnostic performance and the utility of F-18-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET/CT) in the clinical management of patients presenting with lymph node metastasis of undefined primary origin (CUP). A total of 53 patients (34 males, 19 females) with a diagnosis of lymph node metastasis according to the histopathology and/or conventional imaging were enrolled in this retrospective study. Patients were divided into four groups according to the initial location of their metastasis - group 1, cervical lymph nodes (n = 39), group 2, axillary lymph nodes (n = 6), group 3, mediastinal lymph nodes (n = 2) and group 4, abdominal and pelvic lymph nodes (n = 6). The site of a probable primary malignancy suggested by PET/CT was confirmed by biopsy/further investigations or follow-up. 18F-FDG PET/CT accurately detected the primary carcinoma in 19 of 53 patients (36%), with head and neck cancer and lung carcinoma being the most common primary locations. The PET-CT scan results were negative for primary site localization in 13% of patients (false-negative), while 45% had true negative results, and 6% displayed false-positive results. Additional distant metastatic foci were identified in 21 of all patients (40%). The overall sensitivity, specificity, and accuracy rates of the study were identified as 73%, 89%, and 81%, respectively; in the group with cervical lymph node metastasis sensitivity 70% and specificity 84%. To conclude, 18F-FDG PET/CT is a sensitive and selective procedure for detecting unknown primary tumors, especially in the clinical setting of cervical lymph node metastasis and its use should be encouraged earlier in pre-treatment phase of CUP-patients, leading to higher detection of probable primary sites, guiding subsequent biopsy, and more accurate detection of distant metastases in a single examination. |
||
Keywords: cancer of unknown primary; 18F-FDG PET/CT; lymph node metastasis | ||
Published online: 03-Sep-2020 | ||
Year: 2021, Volume: 68, Issue: 1 | Page From: 180, Page To: 189 | |
doi:10.4149/neo_2020_200315N263 |
||
|
download file |
|